Dr. James H. Powell received the B.S. in Chemistry from Virginia Union University, and M.D. from Cornell University Medical College where he also trained in clinical pharmacology and was Assistant Professor of Pharmacology prior to joining the pharmaceutical industry. He retired after 24 years as Senior Medical Director, Global Clinical Pharmacology and Pharmacokinetics for Procter & Gamble Pharmaceuticals in 2006. He directed initial human exposures research for many new drugs and established molecular pharmacology and biomarker capability in support of clinical drug trials. He is a former member of the board of trustees of the Academy of Pharmaceutical Physicians and Investigators and recipient of its Lifetime Honorary Membership Award.
Dr. Powell served as Principal Investigator for the National Medical Association’s Project I.M.P.A.C.T. (Increase Minority Participation and Awareness of Clinical Trials) – a national effort to educate African American and other physicians and consumers on clinical research participation. In this project, he designed programs and directed the education of more than a thousand diverse physicians in skills, ethics, cultural competence, business aspects, and regulatory understanding required for becoming investigators for clinical trials in diverse communities. He was also a member of Baylor College of Medicines EDICT Project (Elimination of Disparities in Clinical Trials). He was appointed to the Secretary of U.S. Health and Human Services Advisory Committee for Human Research Protection (SACHRP), and later served as a member of the National Library of Medicine Board of Regents ClinicalTrials.gov Working Group, and a member of the Schulman and Associates Institutional Review Board. He is on the Board of the “Closing the Health Gap” in Greater Cincinnati and is a founding member, and active in the Alliance of Multicultural Physicians℠ (A collaboration between the Association of Black Cardiologists, the National Hispanic Medical Association, the Association of American Indian Physicians, the National Council of Asian and Pacific Islander Physicians, and the National Medical Association.).
Dr. Powell is co-Founder and Chief Medical Officer for knowRX, Inc., developers of a cloud based digital health platform to enable investigator and patient engagement and inclusion for speed and efficiency in clinical trials, and the knowRX app for personalized medication selection, management, and adherence. Dr. Powell has authored many publications on molecular pharmacology, basic and clinical research, and has conducted numerous lectures and scientific presentations including several on clinical trials in people of color.